Terns Pharmaceuticals, Inc.
TERN
$25.79
-$1.74-6.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.22% | 4.33% | 0.73% | 1.50% | -3.60% |
| Total Depreciation and Amortization | -33.26% | -24.07% | -7.37% | 1.70% | 0.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.27% | -41.71% | -36.16% | -38.43% | -41.48% |
| Change in Net Operating Assets | 11,256.41% | 188.58% | 179.55% | 262.17% | -101.10% |
| Cash from Operations | -3.92% | 5.87% | 5.47% | -3.90% | -26.08% |
| Capital Expenditure | 100.00% | 100.00% | 83.95% | 19.23% | -104.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -132.79% | -146.73% | 68.13% | 67.40% | 229.62% |
| Cash from Investing | -132.82% | -146.79% | 68.15% | 67.33% | 229.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.43% | 1,051.05% | 1,044.37% | 288.66% | 31.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -325.33% | -- | -- | -12.79% | 87.52% |
| Cash from Financing | -99.61% | 1,048.29% | 1,041.63% | 290.92% | 32.44% |
| Foreign Exchange rate Adjustments | -125.37% | -111.05% | -132.67% | -147.86% | 388.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -151.43% | 414.99% | 161.99% | 228.75% | 1,025.86% |